Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,462 across all filing types
Latest filing 2023-08-30 Share Issue/Capital Cha…
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Coloplast A/S - Announcement no. 07/2023 – Coloplast announces completion of offering of 12.2 million new B shares
Share Issue/Capital Change Classification · 1% confidence The document is a formal company announcement (Selskabsmeddelelse) regarding the successful completion of a private placement and share issuance (12.2 million new B shares). It details the capital increase, the listing process on Nasdaq Copenhagen, and includes standard legal disclaimers regarding securities laws and distribution restrictions. Since this is an announcement of a capital change and share issuance rather than a full report or a simple regulatory filing, it falls under the 'Share Issue/Capital Change' category.
2023-08-30 Danish
Coloplast A/S - Announcement no. 07/2023 – Coloplast announces completion of offering of 12.2 million new B shares
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement by Coloplast A/S regarding the successful completion of a directed share offering (12.2 million new B shares). It details the capital increase, the pricing, the lock-up commitments, and the admission to trading on Nasdaq Copenhagen. This falls under the category of share issuance and capital structure changes, which is specifically defined as 'Share Issue/Capital Change' (SHA).
2023-08-30 English
Capital/Financing Update 2023
Capital/Financing Update Classification · 1% confidence The document is a 'Selskabsmeddelelse' (Company Announcement) from Coloplast A/S detailing the launch of an offering ('udbud') to raise approximately 9 billion DKK through the issuance of new B-shares via a private placement and directed issue. This action directly relates to financing activities, specifically raising capital to fund an acquisition (Kerecis). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific capital structure change/fundraising event.
2023-08-29 Danish
Capital/Financing Update 2023
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Coloplast A/S (Announcement no. 06/2023) detailing the launch of an offering to raise approximately DKK 9 billion through the issuance of new B shares via a directed issue and private placement. This action is directly related to financing the acquisition of Kerecis. The core subject is the issuance of new shares to raise capital, which aligns perfectly with the definition of a Capital/Financing Update. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific corporate action related to capital structure change for funding purposes.
2023-08-29 English
Coloplast A/S - Announcement no. 06/2023 – Coloplast launches offering to raise around DKK 9 billion through issue of new B shares in a directed issue and private placement
Share Issue/Capital Change Classification · 1% confidence The document is a formal corporate announcement from Coloplast A/S regarding a new share issuance (capital increase) to raise approximately 9 billion DKK. It details the purpose of the capital raise (funding an acquisition), the process (accelerated book-building), the target investors, and the expected timeline. This falls under the category of share issuance and capital changes.
2023-08-29 Danish
Coloplast A/S - Announcement no. 06/2023 – Coloplast launches offering to raise around DKK 9 billion through issue of new B shares in a directed issue and private placement
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from Coloplast A/S regarding a capital raise of approximately DKK 9 billion through the issuance of new B shares via a directed issue and private placement. It details the purpose of the offering (funding an acquisition), the process (accelerated book-building), and the expected timetable. This falls squarely under the definition of a 'Share Issue/Capital Change' (SHA) announcement, as it describes the company's plan to issue new shares to raise capital.
2023-08-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.